Cognitive impairment in alzheimer's and metabolic diseases: A catecholaminergic hypothesis. Guzman-Ramos K, Osorio-Gomez D, Bermudez-Rattoni F. Neuroscience 2022 May 30. pii: S0306-4522(22)00271.

Read + Share

Amedeo Smart

Independent Medical Education

Guzman-Ramos K, Osorio-Gomez D, Bermudez-Rattoni F. Cognitive impairment in alzheimer's and metabolic diseases: A catecholaminergic hypothesis. Neuroscience 2022 May 30. pii: S0306-4522(22)00271.
PMID: 35654292